Clinical Trial Update: Domvanalimab and Zimberelimab in Advanced Liver Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update examining domvanalimab and zimberelimab in advanced liver cancers, including cholangiocarcinoma and hepatocellular carcinoma, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Drugs mentioned

• Domvanalimab (domvanalimab)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatobiliary Cancer, Liver Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING